about
When prostate cancer remains undetectable: The dilemmaRole of magnetic resonance imaging in defining a biopsy strategy for detection of prostate cancerCUA guidelines on prostate biopsy methodology.The change in serum Thiol/Disulphide homeostasis after transrectal ultrasound guided prostate biopsy.Recent advances in the histopathology and molecular biology of prostate cancer.Prostate cancer: 5. Diagnostic tools for early detectionTransrectal ultrasound and biopsy in the early diagnosis of prostate cancer.Prostate-cancer mortality at 11 years of follow-up.Diagnostic accuracy of prostate needle biopsy.TRUS and prostate biopsy: current status.Prostate biopsy and anaesthesia: an overview.Treatment options for benign prostatic hyperplasia.Organ-wide telomeric status in diseased and disease-free prostatic tissues.Effect of the number of biopsy cores on prostate cancer detection and staging.Management of rising prostate-specific antigen after a negative biopsy.Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis.The rectal administration of lignocaine gel and periprostatic lignocaine infiltration during transrectal ultrasound-guided prostate biopsy provides effective analgesia.Diagnosis of prostate cancer: optimal number of prostate biopsies related to serum prostate-specific antigen and findings on digital rectal examination.Are extended biopsies really necessary to improve prostate cancer detection?Efficiency of 6- and 12-punctures biopsies to detect prostate cancer in patients with PSA </= 10 ng/mL and normal digital rectal examination.Characteristics of patients with stage T1b incidental prostate cancer.Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.Prostate biopsy in Switzerland: a representative survey on how Swiss urologists do it.Anterior apical biopsy: is it useful for prostate cancer detection?Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method.How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer?Enhancing the specificity of prostate-specific antigen (PSA): an overview of PSA density, velocity and age-specific reference ranges.Optimization of prostate cancer diagnosis by increasing the number of core biopsies based on gland volume.Non-prostatic pathology on prostate needle-biopsy - colorectal carcinoid: a case reportTransperineal template prostate biopsies in men with raised PSA despite two previous sets of negative TRUS-guided prostate biopsies.A prospective, randomized trial comparing the Vienna nomogram to an eight-core prostate biopsy protocol.Optimal prostate biopsy regimen.Detailed mapping of prostate carcinoma foci: biopsy strategy implications.Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens.
P2860
Q26795515-8F57DC3F-544A-4FEC-9848-0B46043AE52BQ26998938-27948FFE-BF65-41EB-868A-0EEB0FA78F38Q30482174-CB5D429D-C632-4AA1-8C28-ADD93B7874A3Q33772595-80119BE4-CBC3-46E9-A59C-922DA5159E3CQ33808366-7592083B-4E1E-47A7-815D-C324EE8C8FE4Q34029951-64704018-A307-4FE0-AB1D-7982F824D1C3Q34234513-A6E13537-25B1-42D0-9C63-EAB515D04057Q34261229-5D5396CE-E5DB-4548-A454-99DDAACF3147Q34707104-ED38F0FD-35AB-4651-9AE1-39101AC035F5Q35877194-80E689FD-1C27-4584-B690-36FFF8AEB8B5Q36194992-33F73CB1-21BF-47D9-8A2D-4CA85806BBB6Q36479670-6FDB5E39-06DD-430C-B702-38EE49CCDED9Q37577370-14A9D1F4-5B7D-4C53-88C1-0CEF83272BDDQ37707378-15CAF574-C137-4086-A98D-D142EE77E854Q37846119-06DBCB92-3A94-43A3-AEAD-339E9A629D09Q39159997-F86A53D9-21D0-4652-A192-C3335C59DDEAQ39353462-79EA0F0B-DB30-4CA4-BA70-64D97247C9EEQ39460053-075322E5-77F7-4F2B-B14A-90ED1B0C2D97Q39659562-D7666516-EBAE-4F73-A65A-0B301045C09AQ39709489-44C7E134-30C4-4F9F-8EBB-294517DAB86EQ39727830-0252BD2C-076F-4DB5-898C-0A0E43FC1E69Q39796859-01907F91-F4AF-4B8D-904C-E87B4C66A6B9Q39813133-1DA77DB8-41E9-49EA-85F8-CE90178D965DQ39854896-039D0C04-9C20-402B-AC62-8ACE249C5FBEQ40184478-E88FA03D-6220-43E5-95CE-C58F4C1FB962Q41255229-D42A05F7-ED1B-4B46-A68B-93530DA998D8Q41409532-4DD671D2-6C71-4CAD-B9DB-58CAA5086543Q41625821-A5365DBE-42AB-4E30-A5DA-C563DBB9A327Q42006813-A039B2EF-6EEB-4C8A-B65A-41F2DC933D21Q45986944-DA7E2D93-B85F-4E12-9545-9B2BCC9F1E89Q46383974-A6253EE8-21D9-46EF-8655-66C5FD663BBEQ48123071-A128557B-B18B-4CD5-B6F2-ACCD0193A9F2Q48548961-29F13184-15E0-4767-8CB5-B1C049AA0CC2Q51496034-7609CD83-7FA2-4AFE-9893-D2FE5D98C597Q53565183-73AE971A-E9BE-4C79-BB51-DE1C4D7E8513
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Making the most out of six systematic sextant biopsies.
@en
type
label
Making the most out of six systematic sextant biopsies.
@en
prefLabel
Making the most out of six systematic sextant biopsies.
@en
P1433
P1476
Making the most out of six systematic sextant biopsies.
@en
P2093
T A Stamey
P356
10.1016/S0090-4295(95)96168-2
P407
P577
1995-01-01T00:00:00Z